drugset / Trial / NCT05919615

Use of Tranexamic Acid in the Total Knee Arthroplasty.

NCT05919615 ↗

Completed 100 enrolled Damascus University
RandomizedParallel-groupTriple-blindTreatment

Summary

Tranexamic acid is a medication used to treat or prevent excessive blood loss during surgery. Previous studies have shown tranexamic acid (TXA) reduces blood loss and post-operative blood transfusion rate without significant complications. In addition, many meta-analyses have confirmed these results. This study also aims to determine how safe and effective tranexamic acid treatment is for different patients undergoing primary total knee arthroplasty.

Timeline

Start
2021-07-15
Primary completion
2023-03-15
Completion
2023-03-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications